No profile data available.
StageZero Life Sciences Ltd. (SZLSF) is a healthcare company in the additional medical testing equipment industry, based in Richmond Hill, Canada, with about 40 full-time employees.
It reported revenue of $3.80 million for fiscal year 2022, down 25.1% from fiscal year 2021, and net income of -$11.42 million. In Q3 2024 (the quarter ended September 30, 2024) revenue was $499,663, down 33.0% from a year before. Its market capitalization was $123,532 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2022; market data as of October 8, 2026.
, a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.
StageZero Life Sciences reported $3.80 million in revenue for fiscal year 2022, down 25.1% from $5.07 million in fiscal year 2021. In Q3 2024 revenue was $499,663.
$123,532 as of October 8, 2026.
Listed companies of a similar size in the same industry (additional medical testing equipment) include Trinity Biotech plc (TRIB), Aditxt, Inc. (ADTX), Biomagnetics Diagnostics Corp. (BMGP), Vaxxinity, Inc. (VAXX).